Patents by Inventor Alexander R. L. Cecil

Alexander R. L. Cecil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histone deacetylase inhibitors
    Patent number: 10870624
    Abstract: The present invention is a compound of the formula or a pharmaceutically acceptable salt thereof. The compounds are useful as HDAC inhibitors.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: December 22, 2020
    Assignee: Karus Therapeutics Limited
    Inventors: Stephen J. Shuttleworth, Cyrille D. Tomassi, Alexander R. L. Cecil, Somhairle MacCormick, William J. Nodes, Franck A. Silva
  • Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
    Patent number: 10442815
    Abstract: The invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof and/or stereoisomers thereof. The compounds of the invention are useful in therapy.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: October 15, 2019
    Assignee: Karus Therapeutics Limited
    Inventors: Stephen J. Shuttleworth, Franck A. Silva, Alexander R. L. Cecil, Rikki P. Alexander, Alice E. Gatland, Daniel J. Finnemore
  • TRICYCLIC HETEROCYCLIC COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS
    Publication number: 20180244685
    Abstract: The invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof and/or stereoisomers thereof. The compounds of the invention are useful in therapy.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 30, 2018
    Inventors: Stephen J. Shuttleworth, Franck A. Silva, Alexander R.L. Cecil, Rikki P. Alexander, Alice E. Gatland, Daniel J. Finnemore
  • NOVEL HISTONE DEACETYLASE INHIBITORS
    Publication number: 20180170876
    Abstract: The present invention is a compound of the formula or a pharmaceutically acceptable salt thereof. The compounds are useful as HDAC inhibitors.
    Type: Application
    Filed: August 2, 2017
    Publication date: June 21, 2018
    Inventors: Stephen J. Shuttleworth, Cyrille D. Tomassi, Alexander R. L. Cecil, Somhairle MacCormick, William J. Nodes, Franck A. Silva
  • Histone deacetylase inhibitors
    Patent number: 9862685
    Abstract: The present invention is a compound of the formula or a pharmaceutically acceptable salt thereof. The compounds are useful as HDAC inhibitors.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: January 9, 2018
    Assignee: Karus Therapeutics Limited
    Inventors: Stephen J. Shuttleworth, Cyrille D. Tomassi, Alexander R. L. Cecil, Somhairle MacCormick, William J. Nodes, Franck A. Silva